ZPE-202

· Repros Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZPE-202, covering 2014-02-07 to 2014-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study to ZPE-202 [Phase 2]